OOIR: Observatory of International Research

Papers

(The H4-Index of Kidney International is 60. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
In This Issue	4025
Table of Contents	1134
Subscription Information	615
Taking the A(llorecognition) train: connecting passenger T cells to DSA	425
in this issue	359
Thirsty encounters of the third kind	338
Misuse of the Cox proportional hazards model and alternative approaches in kidney outcome research	324
Title Page	289
Editorial Board	253
Editorial Board	207
Including APOL1 alleles and ancestry adjustments improve a genome-wide polygenic CKD score	195
Function follows form: the quest for the best prognostic imaging biomarker in ADPKD	185
Unexpected metabolic effects of sodium-glucose cotransporter 2 inhibitors	146
Seeing through the density of dense deposit disease	144
Ttc21b deficiency attenuates autosomal dominant polycystic kidney disease in a kidney tubular- and maturation-dependent manner	133
Improving frozen section evaluation of procurement donor kidney biopsies and reducing the discard rate: a promising role for artificial intelligence	131
Gene editing: a near future for the treatment of genetic kidney diseases	127
Neutrophil gelatinase-associated lipocalin is elevated in children with acute kidney injury and sickle cell anemia, and predicts mortality	127
Identification of the gut microbial enzyme turning the urine yellow	122
Challenges in the development of novel methodologies for measuring glomerular filtration rate	120
Proximal-tubule molecular relay from early Protein diaphanous homolog 1 to late Rho-associated protein kinase 1 regulates kidney function in obesity-induced kidney damage	119
Autoimmunoglobulin-triggered extracellular vesicles as new players in membranous nephropathy: friends or foes?	116
A pig kidney supporting human physiology	114
Enhancing kidney organoid maturity with inducible vascularization: another step forward for in vitro modeling	112
Giving monocytes their due: how CD47–SIRP-α reframes allograft rejection	111

The authors reply:	110
Editorial Board	109
The Case \| Progressive submandibular mass and nephrotic syndrome in a young man	104
Podocyte-derived endothelin-1 and endothelial cell endothelin A receptors are essential for glomerular injury in mouse models of focal segmental glomerulosclerosis	95
Unlocking the full potential of human pluripotent stem cell–derived kidney organoids through bioengineering	94
Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today	90
A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease	89
Endothelial but not systemic ferroptosis inhibition protects from antineutrophil cytoplasmic antibody–induced crescentic glomerulonephritis	88
New advances in endocrine hypertension: from genes to biomarkers	88
IL-33 as a component of neutrophil extracellular traps mediates contrast-induced acute kidney injury by promoting ferroptosis in tubular epithelial cells	85
Kidney supportive care: every nephrologist’s business	84
On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome	84
Caloric restriction reduces the pro-inflammatory eicosanoid 20-hydroxyeicosatetraenoic acid to protect from acute kidney injury	80
Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)	79
Multi-omics and imaging mass cytometry characterization of human kidneys to identify pathways and phenotypes associated with impaired kidney function	79
Glomerular-tubular crosstalk via cold shock Y-box binding protein-1 in the kidney	77
Women and kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference	76
Monoclonal immunoglobulin crystalline nephropathies	72
Epigenetic alterations and memory: key players in the development/progression of chronic kidney disease promoted by acute kidney injury and diabetes	70
Kidney protective mechanisms of SGLT2 inhibitors: evidence for a hemodynamic effect	69
The single-cell landscape of the human vein after arteriovenous fistula creation and implications for maturation failure	68
Role of Erythroid Fibroblast Growth Factor 23 in regulating erythropoiesis	68
Blood pressure adaptation in vertebrates: comparative biology	67
Kidney transplantation and hyperbaric oxygen treatment for calciphylaxis	65
Felzartamab: a magic bullet to treat microvascular rejection?	65
Expanding the perspective: addressing additional limitations in cardiovascular risk assessment of immunosuppressive therapies	65
Editorial Board	64
Improving the management of chronic kidney disease in primary care by enhancing laboratory reports with additional information and follow-up procedures	63
Erdheim-Chester disease: hairy kidney and coated aorta	63
The T-cell environment: may the regulatory force be with you	62
Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease	61
RORing toward immunoregulation in glomerulonephritis?	61
Response to the commentary “Modeling pulse wave velocity trajectories—challenges, opportunities, and pitfalls”	61
Letter to the Editor	61
Editorial Board	61